SYMPTOMS – MIM PHARMA

admin123 December 1, 2022 No Comments

An international patent application published under the patent cooperation treaty (PCT)

MIM Pharma’s system-biology-based pharmaceutical composition comprising a mixture of medical plant extracts as active ingredients, and use of said composition as a medicament, particularly in the treatment of human coronavirus infections such as COVID-19 has been published under the patent cooperation treaty (PCT). International Publication Number WO 2022/250542

admin123 May 13, 2022 No Comments

The theoretical and clinical results of MIM Pharma’s antiviral medical solution were published in Elsevier.

Efficacy of a multiple-indication antiviral herbal drug for COVID-19 outpatients: A pre-clinical and randomized clinical trial study The scientific researches on COVID-19 pandemic topics are headed to an explosion of scientific literature. Despite these global efforts, the efficient treatment of patients is an in-progress challenge. Based on a meta-study of published shreds of evidence about […]

Tag: SYMPTOMS

An international patent application published under the patent cooperation treaty (PCT)

The theoretical and clinical results of MIM Pharma’s antiviral medical solution were published in Elsevier.

Recent Post

An international patent application published under the

The theoretical and clinical results of MIM

MIM PHARMA successfully developed a novel natural